Phase II trial of fulvestrant plusenzalutamide in ER+/Her2- advanced breast cancer

Authors
Category Primary study
JournalCancer Research
Year 2021
This article has no abstract
Epistemonikos ID: 55066e3b8be019260ee415a04a99cb7b284ec413
First added on: Feb 12, 2025